Hemorise 100 IV Injection

Hemorise 100 IV 100 mg/2 ml Injection সম্পর্কে

বাংলাদেশে Hemorise 100 IV 100 mg/2 ml Injection ইনজেকশন হিসেবে পাওয়া যায়; এতে Ferric Carboxymaltose আছে (১০০ mg/২ ml)। Hemorise 100 IV প্রস্তুত করেছে The ACME Laboratories Ltd। Hemorise 100 IV-এর সাথে Ferric Carboxymaltose-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

Ferric Carboxymaltose-এর ১৫টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Ferium Injection 500 mg/10 ml-এর, প্রতি ইউনিট ৳ ৭০০।

Hemorise 100 IV 100 mg/2 ml Injection কী?

Made by The ACME Laboratories Ltd., Hemorise 100 IV is a injection whose active ingredient is Ferric Carboxymaltose. Iron is needed to make haemoglobin, which carries oxygen in the blood. It belongs to the group of parenteral iron preparations, meaning iron is supplied directly into the body rather than by mouth. The doctor decides the dose and course based on the patient's weight and needs.

Hemorise 100 IV-এর ব্যবহার

This applies to people who cannot tolerate iron taken by mouth or who have not had a satisfactory response to oral iron. Ask the doctor whether this treatment suits your situation. Ask your doctor whether it is right for your condition.

Hemorise 100 IV কীভাবে ব্যবহার করবেন

Hemorise 100 IV is given by a healthcare professional into a vein; it is not for self-administration at home. Do not inject it yourself unless a doctor has shown you how. Swallow the injection whole with water. The doctor decides the dose, the number of doses and the course, taking into account the patient's weight and condition. The doctor decides the dose and course based on your body weight, your iron needs and your response.

Hemorise 100 IV-এর পার্শ্বপ্রতিক্রিয়া

Because of this, the injection is given where medical staff and treatments are available. The injection site may become discoloured. Some people feel sick or vomit, have a headache, dizziness, flushing, or a change in blood pressure after receiving this injection. Ask your doctor about any side effect that worries you. Contact your doctor if you notice anything unusual after taking it.

সতর্কতা ও নিরাপত্তা

Breastfeeding mothers, people with other medical conditions, and those taking other medicines should ask the doctor first. Hemorise 100 IV can cause serious hypersensitivity reactions, including life-threatening ones. This medicine is in pregnancy category C, meaning animal studies showed adverse effects on the fetus and human data are limited, so a doctor will weigh the benefits and risks. Tell your doctor before treatment if you have had an allergic reaction to iron products or to any ingredient in this injection.

সাধারণ প্রশ্ন

What does Hemorise 100 IV treat?

This applies to people who cannot tolerate iron taken by mouth or who have not had a satisfactory response to oral iron. Ask the doctor whether this treatment suits your situation.

How should I take Hemorise 100 IV?

Hemorise 100 IV is given by a healthcare professional into a vein; it is not for self-administration at home. Do not inject it yourself unless a doctor has shown you how.

Can Hemorise 100 IV cause side effects?

Because of this, the injection is given where medical staff and treatments are available. The injection site may become discoloured.

Is Hemorise 100 IV safe for everyone?

Breastfeeding mothers, people with other medical conditions, and those taking other medicines should ask the doctor first. Hemorise 100 IV can cause serious hypersensitivity reactions, including life-threatening ones.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Ferric Carboxymaltose is indicated for the treatment of iron deficiency anemia in adult patients-
  • Who have intolerance to oral iron or have had unsatisfactory response to oral iron
  • Who have non-dialysis dependent chronic kidney disease.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Non-dextran, IV is a colloidal iron hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron; replaces iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Macrophage engulf FCM from blood and control iron release. Transferrin saturates and, Iron into the liver, spleen and Bone marrow.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

For patients weighing 50 kg or more: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course.

For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.

The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.

Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.

When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.

Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.

Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

There are no known drug interactions and none well documented.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Hypersensitivity to any of its components.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Nausea, Hypertension, Flushing, Decreased blood phosphorus, Dizziness, Vomiting, Pruritus, Rash, Urticaria, Wheezing, Injection site discoloration, Headache, Increased alanine aminotransferase), Dysgeusia, Hypotension, Constipation, Serious anaphylactic/anaphylactoid reactions

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferric carboxymaltose. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferric carboxymaltose administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferric carboxymaltose when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but not limited to, pruritus, rash, urticaria, wheezing, or hypotension may occur.

Hypertension: 
Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Do not store above 30°C. Do not freeze.

বিকল্প ব্র্যান্ড: Ferric Carboxymaltose

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

সব দেখুন ১৫ ব্র্যান্ড

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।